Dietary restrictions do not aid treatment of Meniere disease, according to a study published online Sept. 15 in Frontiers in Nutrition. Wei Gao, from The Fourth Military Medical University in Xi'an, ...
People with Meniere’s disease also often report a feeling of fullness or congestion inside of the ear. The disorder can develop at any age, but it is seen more often in adults between 40 and 60 years ...
SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory, for the treatment of Meniere’s Disease (STOPMD-3) ...
Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for sudden sensorineural hearing loss (SSNHL), according to a study published in ...
Sound Pharmaceuticals Inc.’s lead candidate, the anti-inflammatory SPI-1005 (ebselen), has produced positive pivotal phase III study data in treating Meniere’s disease, an inner-ear disorder that can ...
“All of a sudden, doctor, my ears begin to buzz. The room swirls around me. My eyes jerk and I can’t keep them still. I reel, and if I don’t catch hold of something I fall to the floor. Sometimes I ...
Primemupharma Co. Ltd. has divulged compounds comprising a novel polyester linker acting as antioxidants reported to be useful for the treatment of hearing loss and Meniere’s disease.
PORTLAND, Ore. (KOIN) — I first began to go deaf several years ago when I developed Meniere’s disease, which damaged my inner ear and affected my ability to hear. As I lost my hearing, I relied on a ...
Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere’s Disease with SPI-1005
SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the pivotal Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results